{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:59:49Z","timestamp":1790726389579,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clnesp.2026.102989","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:00:20Z","timestamp":1772038820000},"page":"102989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Investigation of the stool microbiome of short bowel syndrome patients before and after a 24-week treatment with the glucagon-like peptide 2 analog glepaglutide"],"prefix":"10.1016","volume":"73","author":[{"given":"Ismail","family":"Pinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor Sch\u00fctt Svane","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Brach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne Marie","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Henrik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Krogh","family":"Hvistendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berner-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9680-6938","authenticated-orcid":false,"given":"Palle B.","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.102989_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0261-5614(03)00042-6","article-title":"Quality of life and concerns in patients with short bowel syndrome","volume":"22","author":"Carlsson","year":"2003","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"key":"10.1016\/j.clnesp.2026.102989_bib2","first-page":"201","article-title":"Nutritional and medical approaches to intestinal failure","volume":"26","author":"Salazar","year":"2023","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnesp.2026.102989_bib3","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1177\/0148607114520994","article-title":"Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure","volume":"38","author":"Jeppesen","year":"2014","journal-title":"JPEN Journal of Parenteral and Enteral Nutrition"},{"key":"10.1016\/j.clnesp.2026.102989_bib4","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1016\/j.clnu.2021.07.002","article-title":"ESPEN practical guideline: clinical nutrition in chronic intestinal failure","volume":"40","author":"Cuerda","year":"2021","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"key":"10.1016\/j.clnesp.2026.102989_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jviscsurg.2017.12.012","article-title":"Medical and surgical management of short bowel syndrome","volume":"155","author":"Billiauws","year":"2018","journal-title":"Journal of Visceral Surgery"},{"key":"10.1016\/j.clnesp.2026.102989_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.dld.2019.11.013","article-title":"Understanding short bowel syndrome: current status and future perspectives","volume":"52","author":"Massironi","year":"2020","journal-title":"Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"10.1016\/j.clnesp.2026.102989_bib7","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon-like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.clnesp.2026.102989_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jpen.2389","article-title":"Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: findings from a randomized phase 2 trial","volume":"47","author":"Naimi","year":"2023","journal-title":"JPEN Journal of Parenteral and Enteral Nutrition"},{"key":"10.1016\/j.clnesp.2026.102989_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jpen.1767","article-title":"Effect of glepaglutide, a long-acting glucagon-like peptide-2 analog, on gastrointestinal transit time and motility in patients with short bowel syndrome: findings from a randomized trial","volume":"44","author":"Hvistendahl","year":"2020","journal-title":"JPEN Journal of Parenteral and Enteral Nutrition"},{"key":"10.1016\/j.clnesp.2026.102989_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2005.10.004","article-title":"Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans","volume":"130","author":"Meier","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2026.102989_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.regpep.2011.03.003","article-title":"The effect of glucagon-like peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients","volume":"168","author":"Bremholm","year":"2011","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.clnesp.2026.102989_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2012.10.002","article-title":"Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser doppler flowmetry in end-jejunostomy short bowel syndrome patients","volume":"180","author":"H\u00f8yerup","year":"2013","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.clnesp.2026.102989_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0196-9781(99)00176-X","article-title":"Structure, measurement, and secretion of human glucagon-like peptide-2","volume":"21","author":"Hartmann","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.clnesp.2026.102989_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40261-022-01210-1","article-title":"Pharmacokinetics of glepaglutide, a long-acting glucagon-like peptide-2 analogue: a study in healthy subjects","volume":"42","author":"Agersnap","year":"2022","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.clnesp.2026.102989_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.gastro.2024.11.023","article-title":"Glepaglutide, a long-acting glucagon-like peptide-2 analogue, reduces parenteral support in patients with short bowel syndrome: a phase 3 randomized controlled trial","volume":"168","author":"Jeppesen","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2026.102989_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.clnesp.2025.08.006","article-title":"Outcomes of glepaglutide on intestinal absorption and parenteral support in patients with short bowel syndrome","volume":"69","author":"Pinar","year":"2025","journal-title":"Clinical Nutrition ESPEN"},{"key":"10.1016\/j.clnesp.2026.102989_bib17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood.2020005957","article-title":"Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans","volume":"136","author":"Norona","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clnesp.2026.102989_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00280-020-04040-0","article-title":"The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats","volume":"85","author":"Mayo","year":"2020","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.clnesp.2026.102989_bib19","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1038\/s41598-019-52103-x","article-title":"Metabolic and gut microbiome changes following GLP-1 or dual GLP-1\/GLP-2 receptor agonist treatment in diet-induced obese mice","volume":"9","author":"Madsen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2026.102989_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2019.07.006","article-title":"The structure and function of the human small intestinal microbiota: current understanding and future directions","volume":"9","author":"Kastl","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2026.102989_bib21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/2050640619852255","article-title":"Composition of the mucosa-associated microbiota along the entire gastrointestinal tract of human individuals","volume":"7","author":"Vuik","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.clnesp.2026.102989_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41586-023-05989-7","article-title":"Profiling the human intestinal environment under physiological conditions","volume":"617","author":"Shalon","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.clnesp.2026.102989_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.copbio.2014.09.005","article-title":"The small intestine microbiota, nutritional modulation and relevance for health","volume":"32","author":"Aidy","year":"2015","journal-title":"Current Opinion in Biotechnology"},{"key":"10.1016\/j.clnesp.2026.102989_bib24","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/0148607115591216","article-title":"The fecal microbiome in pediatric patients with short bowel syndrome","volume":"40","author":"Davidovics","year":"2016","journal-title":"JPEN Journal of Parenteral and Enteral Nutrition"},{"key":"10.1016\/j.clnesp.2026.102989_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.biochi.2010.02.015","article-title":"Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome","volume":"92","author":"Joly","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.clnesp.2026.102989_bib26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/jgh.13806","article-title":"Fecal microbiota signatures of adult patients with different types of short bowel syndrome","volume":"32","author":"Huang","year":"2017","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.clnesp.2026.102989_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jpen.1595","article-title":"Microbiome and metabolome profiles associated with different types of short bowel syndrome: implications for treatment","volume":"44","author":"Budinska","year":"2020","journal-title":"JPEN Journal of Parenteral and Enteral Nutrition"},{"key":"10.1016\/j.clnesp.2026.102989_bib28","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jpedsurg.2019.08.004","article-title":"Microbial alteration of small bowel stoma effluents and colonic feces in infants with short bowel syndrome","volume":"55","author":"Zhang","year":"2020","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.clnesp.2026.102989_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40168-015-0084-7","article-title":"Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome","volume":"3","author":"Lilja","year":"2015","journal-title":"Microbiome"},{"key":"10.1016\/j.clnesp.2026.102989_bib30","doi-asserted-by":"crossref","first-page":"G154","DOI":"10.1152\/ajpgi.00091.2021","article-title":"Fecal microbiome and bile acid metabolome in adult short bowel syndrome","volume":"322","author":"Boutte","year":"2022","journal-title":"American Journal of Physiology Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.clnesp.2026.102989_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215351","article-title":"The bacterial communities of the small intestine and stool in children with short bowel syndrome","volume":"14","author":"Zeichner","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.clnesp.2026.102989_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature24460","article-title":"Quantitative microbiome profiling links gut community variation to microbial load","volume":"551","author":"Vandeputte","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clnesp.2026.102989_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks808","article-title":"Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies","volume":"41","author":"Klindworth","year":"2013","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.clnesp.2026.102989_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.clnesp.2026.102989_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41564-018-0202-y","article-title":"Recognizing the reagent microbiome","volume":"3","author":"de Goffau","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.clnesp.2026.102989_bib36","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/AEM.01996-06","article-title":"Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities","volume":"73","author":"Lozupone","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.clnesp.2026.102989_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.194497","article-title":"Longitudinal single-cell analysis of glucagon-like peptide-2 treatment in the patients with short bowel syndrome","author":"Kudo","year":"2025","journal-title":"JCI Insight"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:39:35Z","timestamp":1779413975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S2405457726000859"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.102989","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the stool microbiome of short bowel syndrome patients before and after a 24-week treatment with the glucagon-like peptide 2 analog glepaglutide","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.102989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}],"article-number":"102989"}}